You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Mekinist

Showing 1 - 25 of 73
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Tafinlar® + Mekinist® (Dabrafenib + Trametinib)

Recruiting
  • Malignant Melanoma
  • dabrafenib + trametinib
  • Coimbra, Center, Portugal
  • +5 more
Jun 9, 2022

Metastatic Thyroid Cancer Trial in Essen (Trametinib 2 MG [Mekinist], Trametinib 2 MG [Mekinist] and Dabrafenib 75 MG (2-0-2)

Recruiting
  • Metastatic Thyroid Cancer
  • Trametinib 2 MG [Mekinist]
  • Trametinib 2 MG [Mekinist] and Dabrafenib 75 MG (2-0-2) [Tafinlar]
  • Essen, Northrhine-Westphalia, Germany
    Manuel M. Weber
May 17, 2022

Melanoma Trial in Norway (BGB324+pembrolizumab, BGB324+dabrafenib and trametinib, pembrolizumab)

Active, not recruiting
  • Melanoma
  • Bergen, Norway
  • +4 more
Aug 24, 2022

Advanced or Metastatic Solid Tumors Trial (Naporafinib, Trametinib)

Not yet recruiting
  • Advanced or Metastatic Solid Tumors
  • (no location specified)
Jun 21, 2023

Melanoma Trial in Boston (MCS110, Dabrafenib, Trametinib)

Active, not recruiting
  • Melanoma
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Dec 14, 2022

Colorectal Cancer, Pancreatic Adenocarcinoma Trial in Singapore (Trametinib, Ruxolitinib)

Recruiting
  • Colorectal Cancer
  • Pancreatic Adenocarcinoma
  • Singapore, Singapore
    National Cancer Centre
Jun 10, 2022

Advanced Cancer, Solid Tumor Trial in Helsinki, Kuopio, Tampere (Alectinib, Cobimetinib, Vismodegib)

Recruiting
  • Advanced Cancer
  • Solid Tumor
  • Helsinki, Uusimaa, Finland
  • +2 more
Jun 8, 2022

NSCLC Trial in Davis, San Francisco (Ceritinib, Trametinib)

Terminated
  • Non-small Cell Lung Cancer
  • Davis, California
  • +1 more
Dec 22, 2022

Colorectal Cancer, KRAS Wildtype, NRAS Wildtype Trial in Toronto (Trametinib, Panitumumab)

Completed
  • Colorectal Cancer
  • +3 more
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
May 12, 2022

Soft Tissue Sarcoma Trial in France (drug, combination product, other)

Recruiting
  • Soft Tissue Sarcoma
  • Bordeaux, France
  • +17 more
Oct 4, 2022

Metastatic Pancreatic Carcinoma, Stage II Pancreatic Cancer, Stage IIA Pancreatic Cancer Trial in Salt Lake City

Recruiting
  • Metastatic Pancreatic Carcinoma
  • +6 more
  • Salt Lake City, Utah
    Huntsman Cancer Institute/University of Utah
Oct 31, 2022

Metastatic Colorectal Cancer Trial in Boston (Dabrafenib, Trametinib, PDR001)

Recruiting
  • Metastatic Colorectal Cancer
  • Boston, Massachusetts
  • +1 more
Jun 24, 2022

Pancreatic Ductal Adenocarcinoma Trial in Miami (Trametinib, Ruxolitinib, Retifanlimab)

Not yet recruiting
  • Pancreatic Ductal Adenocarcinoma
  • Miami, Florida
    University of Miami
Jun 27, 2022

Metastatic Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer Trial in San Francisco (Capmatinib, Trametinib)

Recruiting
  • Metastatic Lung Non-Small Cell Carcinoma
  • Stage IV Lung Cancer
  • San Francisco, California
    University of California San Francisco
Aug 15, 2022

Advanced Lymphoma, Advanced Malignant Solid Tumor, Hematopoietic and Lymphoid Cell Tumor Trial in Philadelphia (Trametinib

Active, not recruiting
  • Advanced Lymphoma
  • +5 more
  • Trametinib Dimethyl Sulfoxide
  • Philadelphia, Pennsylvania
    ECOG-ACRIN Cancer Research Group
Aug 13, 2022

Prostate Cancer Trial in Los Angeles (degarelix, enzalutamide, trametinib)

Active, not recruiting
  • Prostate Cancer
  • Los Angeles, California
    University of California, Los Angeles
Aug 25, 2022

BRAF NP_004324.2:p.V600E, BRAF V600K Mutation Present, Thyroid Gland Anaplastic Carcinoma Trial in Duarte, Columbus (Dabrafenib,

Recruiting
  • BRAF NP_004324.2:p.V600E
  • +2 more
  • Duarte, California
  • +1 more
Jan 19, 2023

Melanoma Trial in Sydney, Wollstonecraft, Melbourne (Dabrafenib, Trametinib, Pembrolizumab)

Active, not recruiting
  • Melanoma
  • Sydney, New South Wales, Australia
  • +2 more
Apr 4, 2022

Pancreatic Cancer, Adenocarcinoma Trial in Canada (GSK2256098, Trametinib)

Active, not recruiting
  • Pancreatic Cancer
  • Adenocarcinoma
  • Hamilton, Ontario, Canada
  • +3 more
May 12, 2022

Colorectal Cancer, Triple Negative Breast Cancer, NSCLC - Adenocarcinoma Trial in Worldwide (PDR001, ACZ885, CJM112)

Completed
  • Colorectal Cancer, Triple Negative Breast Cancer, NSCLC - Adenocarcinoma
  • PDR001
  • +4 more
  • Baltimore, Maryland
  • +22 more
Mar 15, 2022

Pathologic Stage IIIB Cutaneous Melanoma AJCC v8, Pathologic Stage IIIC Cutaneous Melanoma AJCC v8, Pathologic Stage IIID

Active, not recruiting
  • Pathologic Stage IIIB Cutaneous Melanoma AJCC v8
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 9, 2022

KRAS Mutation-Related Tumors, Metastatic Solid Tumor, Advanced Solid Tumor Trial in United States (TPX-0005, Trametinib)

Active, not recruiting
  • KRAS Mutation-Related Tumors
  • +2 more
  • Los Angeles, California
  • +5 more
Nov 7, 2022

Melanoma Trial in Boston (Trametinib, Dabrafenib, INCB039110)

Active, not recruiting
  • Melanoma
  • Boston, Massachusetts
    Massachusetts General Hospital
Nov 1, 2021

EGFR NP_005219.2:p.S492R, KRAS Gene Mutation, MAP2K1 Gene Mutation Trial in Houston (other, biological, drug)

Recruiting
  • EGFR NP_005219.2:p.S492R
  • +7 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 5, 2022

Bronchial Tumors Trial in Germany, Spain (EGF816, Trametinib)

Recruiting
  • Bronchial Neoplasms
  • Cologne, Germany
  • +6 more
Nov 2, 2022